Cover Image
市場調查報告書

血液篩檢、血型決策的全球市場

Blood Screening and Typing Markets

出版商 Kalorama Information 商品編碼 352106
出版日期 內容資訊 英文 117 Pages
訂單完成後即時交付
價格
Back to Top
血液篩檢、血型決策的全球市場 Blood Screening and Typing Markets
出版日期: 2016年01月20日 內容資訊: 英文 117 Pages
簡介

在血液裡有病毒和細菌,原生動物等,各種感染物質存在。血型檢查和血液檢驗,是對接收者來說確認輸血血液安全的基礎

本報告提供全球血液篩檢、血型決策市場相關調查,市場趨勢與至2020年的成長預測,技術創新趨勢,及主要加入企業簡介彙整。

第1章 摘要整理

第2章 簡介

  • 血型決策的錯誤降低
    • 捐贈者篩檢的改良
    • 病毒篩檢的改良
    • 再捐血率的提高
    • 病毒不活化流程的促進
    • 自願捐血的增加
    • 細菌感染的預防
    • 生物警惕
    • 其他安全警告
  • 血型決策
    • 血型決策的方法
    • 血液檢驗
    • 核酸增幅檢查
    • CBER認證NAT篩檢檢驗
    • 聚合酵素鏈鎖反應 (PCR) 放大
    • CBER認證PCR篩檢檢驗
    • 免疫檢測
    • 酵素免疫吸附法
    • 成本及其他的障礙
    • 血液保存
  • 輸血
  • 血液病原菌篩檢

第3章 市場分析

  • 血液銀行
  • 血型決策
  • 免疫檢測
  • 核酸檢驗
  • 血液檢驗的市場佔有率

第4章 企業簡介

  • Abbott Diagnostics
  • AXO Science
  • Beckman Coulter
  • bioMerieux Inc
  • Cerus Corporation
  • DiaSorin S.p.A
  • Grifols
  • Blood Transfusion Novartis Business
  • International Programs
  • Haemonetics Corporation
  • Hologic, Inc.
  • Product News
  • The Gen-Probe Business
  • Panther System
  • Blood Bank
  • Quest Contract
  • Immucor, Inc.
  • Immunetics Inc.
  • Ortho Clinical Diagnostics
  • Quotient Limited
  • Roche Diagnostics
  • Terumo BCT
  • Verax Biomedical Inc.

圖表

目錄
Product Code: KLI5841881

A variety of infectious agents can be present in blood, including viruses, bacteria, protozoans, Chagas disease, Lyme Disease, and prions. Blood typing and testing represents the cornerstone of ensuring that transfused blood is safe for the recipient and free of disease. Blood Screening and Typing Markets examines the infectious disease blood typing and the infectious disease blood screening markets, including ABO grouping, molecular and nucleic-acid testing (NAT) blood screening, and immunodiagnostic blood screening.

The report provides complete market analysis of the blood screening and typing markets, including:

  • Worldwide Blood Typing and Screening Sales, 2015 and 2020 (ABO Grouping, Immunoassay Screen, NAT Screen)
  • Selected Blood Typing Innovations
  • Blood Typing by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
  • Infectious Disease Blood Typing Market Share by Company
  • Immunoassay Testing Market by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
  • Selected New Blood Screening Immunoassays
  • NAT Blood Screening Market by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
  • Selected New Blood Screen NAT Tests and Systems
  • Infectious Disease Blood Screening Test Market Share by Company

The report provides a comprehensive overview of the blood screening and typing markets, discussing:

  • Risk of Contamination
  • Viral Inactivation by Procedure
  • Basic Blood Types
  • Blood Transfusion Compatibility
  • PCR-Based Screening Tests Licensed by CBER
  • Comparison of Direct and Indirect ELISA Tests
  • Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries
  • Blood Component Usage
  • Pathogens Commonly Tested in Donated Blood Units
  • Selected Pathogen Screening Innovations

Blood Screening and Typing Markets profiles a selection of companies that specialize in blood banking and that contribute molecular test innovation to this segment. Companies discussed include:

  • Abbott Diagnostics
  • AXO Science
  • Beckman Coulter
  • bioMérieux Inc.
  • Cerus Corporation
  • DiaSorin S.p.A.
  • Grifols
  • Haemonetics Corporation
  • Hologic, Inc.
  • Immucor, Inc.
  • Immunetics Inc.
  • Ortho Clinical Diagnostics
  • Quotient Limited
  • Roche Diagnostics
  • Terumo BCT
  • Verax Biomedical Inc.

Table of Contents

ONE: EXECUTIVE SUMMARY

  • Blood Screening
  • Blood Typing
  • The Market for Blood Testing and Typing

TWO: INTRODUCTION

  • Reducing Blood Typing Errors
  • Improving Donor Screening
  • Improving Viral Screening
  • Increasing Repeat Donation Rates
  • Enhancing Viral Inactivation Processes
  • Increasing Voluntary Donation
  • Preventing Bacterial Infections
  • Biovigilance
  • Other Safety Precautions
  • Blood Typing
  • Methods of Blood Typing
  • Blood Testing
  • Nucleic Acid Amplification Testing (NAT)
  • CBER Licensed NAT Screening Tests
  • Polymerase Chain Reaction (PCR) Amplification
  • CBER Licensed PCR Screening Tests
  • Immunoassay
  • Enzyme-Linked Immunosorbent Assay
  • Costs and Other Barriers
  • Blood Storage
  • Blood Transfusions
  • Blood Pathogen Screening

THREE: MARKET ANALYSIS

  • Blood Banking Gets a Shakeup
  • Blood Typing
  • Blood Grouping and Typing
  • Immunoassays
  • Nucleic Acid Testing (NAT)
  • Market Share in Blood Testing

FOUR: COMPANY PROFILES

  • Abbott Diagnostics
  • AXO Science
  • Beckman Coulter
  • bioMérieux Inc
  • Cerus Corporation
  • DiaSorin S.p.A
  • Grifols
  • Blood Transfusion Novartis Business
  • International Programs
  • Haemonetics Corporation
  • Hologic, Inc.
  • Product News
  • The Gen-Probe Business
  • Panther System
  • Blood Bank
  • Quest Contract
  • Immucor, Inc.
  • Immunetics Inc.
  • Ortho Clinical Diagnostics
  • Quotient Limited
  • Roche Diagnostics
  • Terumo BCT
  • Verax Biomedical Inc.

LIST OF EXHIBITS

ONE: EXECUTIVE SUMMARY

  • Figure 1-1: The Market for Blood Testing and Typing, 2015 and 2020

TWO: INTRODUCTION

  • Table 2-1: Risk of Contamination
  • Table 2-2: Viral Inactivation by Procedure
  • Table 2-3: Basic Blood Types
  • Table 2-4: Blood Transfusion Compatibility
  • Table 2-5: PCR-Based Screening Tests Licensed by CBER
  • Table 2-6: Comparison of Direct and Indirect ELISA Tests
  • Table 2-7: Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries
  • Table 2-8: Blood Component Usage
  • Table 2-9: Pathogens Commonly Tested in Donated Blood Units
  • Table 2-10: Selected Pathogen Screening Innovations

THREE: MARKET ANALYSIS

  • Table 3-1: Worldwide Blood Typing and Screening Sales, 2015 and 2020 (ABO Grouping, Immunoassay Screen, NAT Screen)
  • Figure 3-1: Worldwide Blood Typing and Screening Sales, 2015 and 2020 (ABO Grouping, Immunoassay Screen, NAT Screen)
  • Table 3-2: Selected Blood Typing Innovations
  • Figure 3-2: Blood Typing by Country, 2015 (United States, Italy, Germany, UK,
  • France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
  • Table 3-3: Infectious Disease Blood Typing Market Share by Company
  • Figure 3-3: Immunoassay Testing Market by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
  • Table 3-4: Selected New Blood Screening Immunoassays
  • Figure 3-4: NAT Blood Screening Market by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
  • Table 3-5: Selected New Blood Screen NAT Tests and Systems
  • Table 3-6: Infectious Disease Blood Screening Test Market Share by Company
Back to Top